Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1697875

registered interest
date	21/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Dorset
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential impact of the extra allocations of money made from the discharge fund to the (a) NHS and (b) local authorities in Dorset in the 2023-24 financial year on the (i) timeliness and (ii) effectiveness of the discharge of patients from NHS hospitals.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	19766
answer	answer is ministerial correction date of answer 28/03/2024 answer text <p>The Government is investing an additional £600 million for 2023/24 and £1 billion for 2024/25, through the Discharge Fund, to support the National Health Service and local authorities in ensuring timely and effective discharge from hospital. As part of their allocations for 2023/24, NHS Dorset Integrated Care Board received £5.7 million, Bournemouth, Christchurch and Poole Council received £1.9 million, and Dorset Council received £1.7 million. There will be an independent evaluation of the Discharge Fund for 2023/24 and 2024/25.</p><p>Nationally, this funding has supported more people to be discharged more quickly with more appropriate support. The number of people discharged from hospital with packages of health and social care support increased by 10% between the end of February 2023 and the end of February 2024. Thanks to this improved patient flow hospitals have been able to admit and treat more patients during this period.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 28/03/2024 12:08:27 answering member 4527 label Biography information for Helen Whately previous answer version 26254 answering member constituency Faversham and Mid Kent answering member printed Helen Whately answering member 4527 label Biography information for Helen Whately
tabling member	242 label Biography information for Sir Christopher Chope

1697032

registered interest
date	19/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Food: Labelling
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help ensure retail food businesses comply with measures in the Food Information Regulations 2014 on providing written allergen information for labels.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	19237
answer	answer is ministerial correction date of answer 25/03/2024 answer text <p>The Food Standards Agency (FSA) is responsible for food safety related labelling, including allergens. Local authorities are responsible for enforcing food law in the vast majority of food businesses, including those in the retail and catering sector. As central competent authority, the FSA monitors the delivery of official controls by local authorities.</p><p>The FSA produces the statutory Food Law Code of Practice and associated Practice Guidance establishing a set of expectations for the activities local authorities are responsible for under food law, and how these are to be delivered. This is supported by a range of training, advice, and guidance to help food officers discharge their functions. Recent changes to the Food Law Code of Practice will enable a more risk-based and intelligence-driven approach to targeting premises for food standards inspections and carrying out interventions, and includes specific consideration of the risk factor for compliance with providing allergen information.</p><p>The FSA also provides support for food businesses, for example through guidance and training, on providing allergen information in line with the requirements of the 2014 Food Information to Consumer Regulations to help drive up compliance and make it easier for people with a food allergy, intolerance, and coeliac disease to make safe choices when eating out.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 25/03/2024 11:12:22 answering member 4117 label Biography information for Andrea Leadsom
tabling member	242 label Biography information for Sir Christopher Chope

1696697

registered interest
date	18/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Skin Diseases: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the effectiveness of drugs available within the NHS to treat (a) epidermolysis bullosa and (b) other inflammatory skin conditions.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	18966
answer	answer is ministerial correction date of answer 21/03/2024 answer text <p>The National Institute for Health and Care Excellence (NICE) makes independent, evidence-based recommendations for the National Health Service on whether new licensed medicines should be routinely funded by the NHS, based on an assessment of their costs and benefits.</p><p>Currently, there is one product licensed specifically for epidermolysis bullosa, Filsuvez gel, which contains birch bark extract. The NICE recommends birch bark extract as a clinically and cost effective use of NHS resources, and the NHS is legally required to fund it in line with the NICE’s recommendations. Other healthcare products are also used in the care of epidermolysis bullosa patients. There are a number of licensed and NICE recommended treatments for other inflammatory skin conditions that are now routinely available for NHS patients.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 21/03/2024 12:21:44 answering member 4044 label Biography information for Andrew Stephenson
tabling member	242 label Biography information for Sir Christopher Chope

1696500

registered interest
date	15/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will (a) publish average weight to height ratios for children in England and (b) provide advice on any health implications for those who have a ratio significantly larger or smaller than the average.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	18830
answer	answer is ministerial correction date of answer 21/03/2024 answer text <p>The National Child Measurement Programme (NCMP) collects data on the height and weight status of children aged four to five years old, who are in Reception, and 10 to 11 years old, who are in Year six. The data collected and published by NHS England is expressed as a Body Mass Index (BMI) centile, to estimate child overweight and obesity. Data on average weight to height ratios for children in England is not available. The Department does not plan to publish data on average weight to height ratios, or average waist to height ratios for children in England. Waist measurements are not collected as part of the NCMP.</p><p>The clinical guidance from the National Institute of Health and Care Research recommends that a waist to height ratio measurement is considered alongside a child’s BMI centile in individual clinical assessments, to give a practical estimate of central adiposity. If a child falls into an unhealthy weight category, a waist to height ratio will give additional health information in clinical settings. This includes helping to assess and predict individual health risks such as type 2 diabetes, hypertension, or cardiovascular disease, as the location of where children carry weight on their bodies has an influence on their health.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 21/03/2024 13:45:32 answering member 4117 label Biography information for Andrea Leadsom
tabling member	242 label Biography information for Sir Christopher Chope

1696501

registered interest
date	15/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Euthanasia: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact on NHS services of the introduction of legislation to permit assisted dying.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	18831
answer	answer is ministerial correction date of answer 27/03/2024 answer text <p>No assessment has been made.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 27/03/2024 10:47:43 answering member 4527 label Biography information for Helen Whately
tabling member	242 label Biography information for Sir Christopher Chope

1695751

registered interest
date	13/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Yellow Card Scheme: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many Yellow Cards for covid-19 vaccinations were (a) identified by the MHRA as being of special interest and (b) followed up by the MHRA in (i) 2021, (ii) 2022 and (iii) 2023.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	18344
answer	answer is ministerial correction date of answer 18/03/2024 answer text <p>Adverse events of special interest (AESI) are medical events or conditions that have been identified as possible vaccine safety concerns, based mainly on previous experience with other vaccines and immune-mediated events which theoretically may occur, as vaccines stimulate an immune response. AESIs for COVID-19 vaccines were subject to enhanced surveillance by the Medicines and Healthcare products Regulatory Agency (MHRA) and many other regulators from the start of the United Kingdom’s immunisation programme.</p><p>Specifically in relation to AESIs, the MHRA has received 22880 UK spontaneous suspected adverse reaction (ADR) reports across all COVID-19 vaccines. Over 157 million doses of COVID-19 vaccines have been given in the UK. It is important to note that Yellow Card reports are not proof of a side effect occurring, and the incidence of a reaction occurring cannot be determined by these reports. The MHRA considers that the benefits of the COVID-19 vaccines continue to outweigh the risks for the majority of people.</p><p>The MHRA acknowledges receipt of every Yellow Card report received, and a team of safety experts follow up for additional information as necessary, including consideration of reports with a fatal outcome, based on the completeness, severity, and clinical details provided in the report. Responses to follow-up requests for ADR reports are recorded and stored with the original report on our ADR database. The information is then passed downstream for use in signal detection and the identification of safety concerns.</p><p>The data is available for its core purpose of assessment and signal detection, however, the systems were not designed to quantify follow-up metrics requested in this parliamentary question. As such it is not possible to automatically generate metrics on the proportion of follow-up requests sent. The MHRA has provided information on follow up rates under Freedom of Information, within the 20 day statutory timeframes based on manual review of reports, and is committed to publishing high level data on its website.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 18/03/2024 17:44:25 answering member 4492 label Biography information for Maria Caulfield
tabling member	242 label Biography information for Sir Christopher Chope

1695752

registered interest
date	13/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Yellow Card Scheme: Medical Records
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, on what date work on digitally linking Medicines and Healthcare products Regulatory Authority Yellow Card information to NHS clinical records (a) began and (b) is expected to be completed.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	18345
answer	answer is ministerial correction date of answer 22/03/2024 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) has been working with the National Health Service to explore approaches to facilitate digital linkage of Yellow Card information to clinical records, and to potentially enable faster access to information, where considered necessary for an assessment. Any such approach would be subject to strict information governance controls and prior consultation with stakeholder groups.</p><p>In 2020, the MHRA began delivery of a substantially enhanced Yellow Card platform under the SafetyConnect programme, aligned to the recommendations in Baroness Cumberlege’s Independent Medicines and Medical Devices Safety Review. The new infrastructure is designed with the intent of enabling connectivity to other systems, to facilitate the exchange of information. During that time the MHRA has engaged with the NHS around the evolving technical options for robust and secure connectivity and enhanced user journeys. The first step in these enhancements is use of the common NHS login capability within Yellow Card, which is expected to go live in 2024.</p><p>Deeper connectivity between systems will be subject to internal and external stakeholder engagement and substantial information governance controls, with elements completed over a phased and multi-year work plan.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 22/03/2024 10:33:41 answering member 4044 label Biography information for Andrew Stephenson previous answer version 24322 answering member constituency Pendle answering member printed Andrew Stephenson answering member 4044 label Biography information for Andrew Stephenson
tabling member	242 label Biography information for Sir Christopher Chope

1695753

registered interest
date	13/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Safety
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Coroner’s report entitled Oli Hoque: Prevention of future deaths report, published on 13 October 2022, what steps NHS England is taking to allow the Medicines and Healthcare products Regulatory Authority to compel the timely production of clinical data when conducting investigations into harms arising from regulated medicines.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	18346
answer	answer is ministerial correction date of answer 20/03/2024 answer text <p>The NHS England National Patient Safety Team and the Medicines and Healthcare products Regulatory Agency (MHRA) routinely work closely on both system development, and a number of safety issues. The NHS England National Patient Safety Team have a data sharing agreement with the MHRA, and provide regular sharing of patient safety incidents reported to NHS England, that are classified as medication incidents or medical device incidents. In addition, the MHRA are able to request focussed searches of reported incidents if they are working on a specific issue.</p><p> </p><p>However, the MHRA does not have the legal powers to compel healthcare professionals to provide additional information after an initial report of a suspected adverse reaction. The MHRA has been working with the National Health Service to explore approaches to facilitate digital linkage of Yellow Card information to clinical records, and potentially to enable faster access to information, where considered necessary for an assessment. This work remains ongoing.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 20/03/2024 14:49:56 answering member 4492 label Biography information for Maria Caulfield previous answer version 24319 answering member constituency Pendle answering member printed Andrew Stephenson answering member 4044 label Biography information for Andrew Stephenson
tabling member	242 label Biography information for Sir Christopher Chope

1692184

registered interest
date	27/02/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospital Beds: Dorset
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many beds were occupied by patients ready to be discharged in NHS hospitals in Dorset; and how many of these patients had been awaiting discharge for more than (a) three days, (b) seven days and (c) a month on the most recent date for which data is available.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	15833
answer	answer is ministerial correction date of answer 05/03/2024 answer text <p>On 31 January 2024, there were 308 patients with No Criteria To Reside (NCTR) in acute hospitals in Dorset, 77 patients in Dorset County Hospital Foundation Trust and 231 patients in University Hospitals Dorset NHS Foundation Trust.</p><p>NHS England publishes data on the proportion of patients discharged on their discharge-ready date and the lengths of delay for those discharged after this date, up to a delay of 21 days or more. The latest published figures are for December 2023.</p><p>For Dorset County Hospitals NHS Foundation Trust, 91% of patients were discharged on their discharge-ready date. Of the 9% of patients who were discharged after this date, 47.6% were delayed four or more days, 32% were delayed seven or more days, and 10.7% were delayed 21 or more days.</p><p>For University Hospitals Dorset Foundation Trust, 84.2% of patients were discharged on their discharge-ready date. Of the 15.8% of patients discharged after this date, 50.4% were delayed four or more days, 33.5% were delayed seven or more days, and 9% were delayed 21 or more days.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 05/03/2024 13:28:07 answering member 4527 label Biography information for Helen Whately previous answer version 20890 answering member constituency Faversham and Mid Kent answering member printed Helen Whately answering member 4527 label Biography information for Helen Whately
tabling member	242 label Biography information for Sir Christopher Chope

1692229

registered interest
date	27/02/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Christchurch Hospital
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when work on the Christchurch Hospital Macmillan Unit building project included in the New Hospital programme will begin.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	16052
answer	answer is ministerial correction date of answer 06/03/2024 answer text <p>As set out in the Trust's Full Business Case, it has been agreed that works at Christchurch Hospital, including those to enable the MacMillan palliative unit, are being funded and taken forward by the trust directly, in collaboration with the Macmillan Caring Locally Charity.</p><p> </p><p>The New Hospital Programme will be building a new hospital for Dorset Healthcare University NHS Foundation Trust at Alumhurst Road as supported by the local and regional health system.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 06/03/2024 12:46:08 answering member 4044 label Biography information for Andrew Stephenson previous answer version 20896 answering member constituency Pendle answering member printed Andrew Stephenson answering member 4044 label Biography information for Andrew Stephenson
tabling member	242 label Biography information for Sir Christopher Chope